Stocks in play: Pivotree Inc.

Reported financial results for the three-month period ended September 30, 2022. Total Revenue of $24.6 million, an increase of 53.7% or 49% in constant currency. Adjusted for the estimated revenue from acquisitions, organic growth would be 8.5%. Gross profit of $11.0 million, an increase of 55.0% and representing 44.9% of total revenue. Net loss of $3.6 million compared to a net loss of $3.3 million for the prior year period. Pivotree Inc. shares V.PVT are trading up $0.08 at $3.50.

Read:

• Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer

• New Biotech Sector Drug Combinations Target a Drop in Pancreatic Cancer Mortality Rates

• Highly Sought After Natural Ingredients Appearing in More Plant-Based Products Across North America

• Fresher, Healthier Food Options Coming Soon to an Airplane Tray Near You

• Airline Industry Wooing Back Customers with Enhanced, Healthier Menu Options